XML 36 R19.htm IDEA: XBRL DOCUMENT
v3.25.4

Note 9 - Income Taxes | 12 Months Ended
--- | ---
Dec. 31, 2025
Notes to Financial Statements |
Income Tax Disclosure [Text Block] | 9. Income Taxes The Company did not provide for income taxes during the periods presented because it had book and federal taxable losses in those years and the tax benefit that would have resulted from the pre-tax losses was fully offset by a change in the valuation allowance. The reconciliation of the statutory federal income tax rate to the Company’s effective tax rate for periods presented was as follows:
|  | Year ended December 31, |
|  | 2025 |  |  | 2024 |  |  | 2023 |
U.S. federal statutory tax rate |  | $ | (19,104 | ) |  |  | 21 | % |  |  | 21 | % |  |  | 21 | %
Nontaxable or nondeductible items |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Stock compensation |  |  | 3,580 |  |  |  | (4.0 | ) |  |  | (5.7 | ) |  |  | 0.2 |
Section 162(m) limitation |  |  | — |  |  |  | — |  |  |  | (0.2 | ) |  |  | — |
Change in fair value of warrant liabilities |  |  | — |  |  |  | — |  |  |  | 93.3 |  |  |  | — |
SEC settlement payment |  |  | — |  |  |  | — |  |  |  | (34.5 | ) |  |  | — |
Change in valuation allowance |  |  | 15,207 |  |  |  | (16.7 | ) |  |  | (79.4 | ) |  |  | (24.0 | )
Tax Credits |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Research and development credits |  |  | (1,021 | ) |  |  | 1.1 |  |  |  | 15.4 |  |  |  | 5.1 |
Tax attribute expiration |  |  | 922 |  |  |  | (1.0 | ) |  |  | (4.1 | ) |  |  | — |
Uncertain tax positions |  |  | 409 |  |  |  | (0.4 | ) |  |  | (6.1 | ) |  |  | (2.0 | )
State tax, net of federal benefit |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |
Other |  |  | 7 |  |  |  | — |  |  |  | 0.3 |  |  |  | (0.3 | )
Effective income tax rate |  | $ | — |  |  |  | — | % |  |  | — | % |  |  | — | %
Deferred tax assets and valuation allowance Deferred tax assets reflect the tax effects of net operating loss and tax credit carryforwards and temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. The Company’s deferred taxes assets at December 31, 2025 and 2024 were valued at the corporate tax rate of 21%. The Company offsets its deferred tax assets by a valuation allowance because it is uncertain about the timing and amount of any future profits. Significant components of its deferred tax assets are as follows (in thousands):
|  | December 31, |
|  | 2025 |  |  | 2024 |
Deferred tax assets: |  |  |  |  |  |  |  |
Net operating loss carryforwards |  | $ | 78,632 |  |  | $ | 43,148 |
Legal reserves |  |  | 6,563 |  |  | $ | — |
Share-based compensation |  |  | 5,319 |  |  |  | 4,814 |
Research and development credit carryforwards |  |  | 13,480 |  |  |  | 13,789 |
Capitalized research and development expenses |  |  | 6,919 |  |  |  | 33,598 |
Other |  |  | 985 |  |  |  | 1,340 |
Total deferred tax assets |  |  | 111,898 |  |  |  | 96,689 |
Valuation allowance |  |  | (111,896 | ) |  |  | (96,689 | )
Net deferred tax assets |  |  | 2 |  |  |  | — |
Deferred tax liabilities: |  |  |  |  |  |  |  |
Intangibles |  |  | (2 | ) |  |  | — |
Total deferred tax liabilities |  |  | (2 | ) |  |  | — |
Net deferred tax asset (liability) |  | $ | — |  |  | $ | — |
The valuation allowance increased by $15.1 million and $19.4 million in 2025 and 2024, respectively, due primarily to continuing operations. The Company’s net operating loss carryforwards of $374.4 million are federal, of which $74.1 million expires between 2029 and 2037 and $300.3 million carries forward indefinitely. As of December 31, 2025, the Company had federal research and development tax credits of approximately $22.4 million, which expire in the years 2026 through 2045. Unrecognized tax benefits As of December 31, 2025, 2024 and 2023, the Company has unrecognized tax benefits related to tax credits of $9.0 million, $9.2 million and $8.4 million, respectively. None of the unrecognized tax benefits as of December 31, 2025, if recognized, would impact the effective tax rate due to the valuation allowance and no interest or penalties have been recognized. A reconciliation of the beginning and ending balance of unrecognized tax benefits is as follows (in thousands):
|  | Year ended December 31, |
|  | 2025 |  |  | 2024 |  |  | 2023 |
Beginning balance |  | $ | 9,242 |  |  | $ | 8,413 |  |  | $ | 6,496 |
Expired research and development tax credits |  |  | (614 | ) |  |  | (665 | ) |  |  | (50 | )
Additions based on tax positions related to the current year |  |  | 392 |  |  |  | 1,494 |  |  |  | 1,967 |
Ending balance |  | $ | 9,020 |  |  | $ | 9,242 |  |  | $ | 8,413 |
As of December 31, 2025, there were no unrecognized tax benefits that we expect would change significantly over the next 12 months. The Company files U.S. and Texas income tax returns. In the United States, the statute of limitations with respect to the federal income tax returns for tax years after 2021 are open to audit; however, since the Company has net operating losses, the taxing authority has the ability to review tax returns prior to the 2022 tax year and make adjustments to these net operating loss carryforwards. We are not under audit in any taxing jurisdiction at this time.

X
- References No definition available. + Details
Name: | us-gaap_DisclosureTextBlockAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for income tax. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 942 -SubTopic 740 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477617/942-740-50-1 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 235 -SubTopic 10 -Name Accounting Standards Codification -Section S50 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 944 -SubTopic 740 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147478822/944-740-50-1 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 740 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 12 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12 Reference 5: http://www.xbrl.org/2003/role/exampleRef -Topic 740 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 231 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 740 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 12C -Publisher FASB -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12C Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Topic 740 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 12B -Publisher FASB -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12B Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Topic 740 -SubTopic 270 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org/1943274/2147477891/740-270-50-1 Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Topic 740 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SAB Topic 6.I.5.Q1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1 Reference 10: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 13 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480990/946-20-50-13 Reference 11: http://www.xbrl.org/2003/role/disclosureRef -Topic 235 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08(h)(2)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1 Reference 12: http://www.xbrl.org/2003/role/disclosureRef -Topic 740 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/740/tableOfContent Reference 13: http://www.xbrl.org/2003/role/disclosureRef -Topic 740 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 14 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482685/740-10-50-14 Reference 14: http://www.xbrl.org/2003/role/disclosureRef -Topic 740 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 21 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482685/740-10-50-21 Reference 15: http://www.xbrl.org/2003/role/disclosureRef -Topic 740 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 17 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482685/740-10-50-17 Reference 16: http://www.xbrl.org/2003/role/disclosureRef -Topic 740 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 2 -Subparagraph (SAB Topic 11.C) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-2 Reference 17: http://www.xbrl.org/2003/role/disclosureRef -Topic 740 -SubTopic 30 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482603/740-30-50-2 + Details
Name: | us-gaap_IncomeTaxDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration